```html

Yeast Overgrowth in the Small Intestine (SIBO)

Overview

Small‑Intestinal Bacterial Overgrowth (SIBO) refers to an abnormal increase in the number or type of microorganisms—most often bacteria, but sometimes yeast (fungi)—in the small intestine. While the large intestine is designed to house a dense microbial community, the small intestine normally contains relatively few organisms. When yeast proliferates excessively, it can cause a range of gastrointestinal (GI) and systemic symptoms.

SIBO is not limited to any single age group, but it is most commonly diagnosed in adults between 30‑70 years old. Epidemiological studies estimate that up to 15 % of the general population may have SIBO at some point, with higher rates (up to 30‑40 %) in individuals with IBS, celiac disease, or diabetes.

Symptoms

Symptoms result from fermentation of carbohydrates by the overgrown organisms, producing gas, acids, and toxins that irritate the intestinal lining. The presentation can be variable, and many patients experience overlapping features.

Gastrointestinal Symptoms

• Bloating and distention – a feeling of fullness or a visibly swollen abdomen, often worsening after meals.
• Excessive gas – flatulence or belching that may be foul‑smelling.
• Abdominal pain or cramping – usually lower‑mid‑abdomen; may be relieved or triggered by passing gas.
• Diarrhea – watery or loose stools, sometimes alternating with constipation.
• Constipation – hard, infrequent stools; can coexist with diarrhea (so‑called “mixed” pattern).
• Steatorrhea (fatty stools) – stools that float, appear oily, or have a foul odor, indicating malabsorption.
• Nausea or early satiety – feeling full after only a few bites.

Systemic & Extra‑intestinal Symptoms

• Fatigue or brain fog – difficulty concentrating, memory lapses, or feeling “cloudy.”
• Joint or muscle aches – low‑grade inflammatory pain that may be mistaken for arthritis.
• Skin changes – eczema, rashes, or acne‑like eruptions linked to toxin release.
• Unexplained weight loss – due to malabsorption of nutrients.
• Vitamin deficiencies – especially B‑12, iron, and fat‑soluble vitamins (A, D, E, K).

Causes and Risk Factors

SIBO develops when normal protective mechanisms of the small intestine are impaired, allowing microbes (including yeast) to proliferate.

Primary Mechanisms

• Motility disorders – conditions that slow intestinal transit (e.g., scleroderma, diabetes‑related autonomic neuropathy, opioid use) give microbes time to ferment.
• Structural abnormalities – blind loops, strictures, surgical blind‑ends (e.g., after gastric bypass), or diverticula create niches where organisms can hide.
• Low stomach acid – hypochlorhydria (often from chronic PPI use) reduces the natural barrier that kills swallowed microbes.
• Immune dysfunction – HIV, immunosuppressive therapy, or primary immunodeficiencies decrease the body’s ability to keep yeast in check.

Risk Factors

• Chronic use of proton‑pump inhibitors (PPIs) or H2 blockers.
• Prior abdominal surgery (e.g., Roux‑en‑Y, ileal resection).
• Functional GI disorders such as Irritable Bowel Syndrome (IBS).
• Diabetes mellitus with autonomic neuropathy.
• Connective‑tissue diseases (scleroderma, lupus).
• Long‑term antibiotic or antifungal therapy that disrupts normal flora.
• Age > 65 years (natural decline in motility).

Diagnosis

Diagnosing SIBO, especially yeast‑predominant overgrowth, requires a combination of clinical suspicion, breath testing, and occasionally direct sampling.

Breath Tests

• Hydrogen Breath Test (HBT) – measures hydrogen gas produced by bacterial fermentation of a lactulose or glucose substrate.
• Methane Breath Test – detects methane (often produced by archaea) which can coexist with yeast.
• Combined Hydrogen & Methane Test – the most common clinical tool; a rise of ≥20 ppm H₂ or ≥10 ppm CH₄ within 90 minutes is considered positive (CDC).

Yeast overgrowth may not always produce a classic breath‑test pattern, so a negative result does not rule it out.

Direct Aspiration & Culture

Upper endoscopy with duodenal aspirate allows quantitative culture. A bacterial count >10⁵ CFU/mL (or >10³ CFU/mL for yeast) is diagnostic, but the procedure is invasive and not routinely performed.

Stool and Blood Tests

• Comprehensive stool analysis can reveal fungal overgrowth (Candida spp.) and dysbiosis.
• Serum vitamin B12, iron, folate, and vitamin D levels help assess malabsorption.

Imaging

Abdominal CT or MRI may identify anatomic causes (strictures, blind loops) that predispose to SIBO.

Treatment Options

Therapy targets three goals: eradicate the overgrowth, restore normal motility, and prevent recurrence.

Antimicrobial Regimens

• Rifaximin – a non‑systemic antibiotic effective against gram‑negative bacteria; typical dose 550 mg three times daily for 14 days (FDA‑approved for IBS‑D with SIBO).
• Neomycin – often combined with rifaximin for methane‑dominant SIBO.
• Azole antifungals – fluconazole 200 mg daily for 2‑4 weeks or itraconazole for confirmed yeast overgrowth.
• Herbal antimicrobials – oregano oil, berberine, garlic extract; evidence emerging (NIH).

Prokinetic Agents (Motility Enhancers)

• Low‑dose erythromycin or azithromycin (motilin agonists).
• Prucalopride or tegaserod for chronic constipation‑type SIBO.
• Diet‑driven “carb‑cycling” (alternating low‑FODMAP days) to reduce substrate for microbes.

Dietary Strategies

• Low‑FODMAP diet – limits fermentable oligo‑, di‑, mono‑saccharides and polyols that feed yeast.
• Specific Carbohydrate Diet (SCD) – removes complex carbs, focusing on monosaccharides.
• Gradual re‑introduction of fibers after eradication to support a healthy microbiome.

Supplemental Support

• Probiotics containing Lactobacillus and Bifidobacterium strains (e.g., L. rhamnosus GG) may help rebalance flora after antibiotics.
• Digestive enzymes and betaine HCl (if low stomach acid is suspected) under physician guidance.
• Vitamin B12, D, and iron supplementation when labs show deficiency.

Procedural Options

• Enteric‑coated antibiotic delivery (e.g., Rifaximin) – minimizes systemic exposure.
• Endoscopic removal of strictures or blind loops – indicated when structural lesions perpetuate SIBO.

Living with Yeast Overgrowth in Small Intestine (SIBO)

Long‑term management focuses on symptom control, nutrition, and preventing relapse.

Daily Management Tips

• Meal timing – eat smaller, more frequent meals (4‑6 per day) to avoid large boluses that delay gastric emptying.
• Chew thoroughly – improves mechanical digestion and reduces fermentable load.
• Stay hydrated – 1.5–2 L of water daily supports motility.
• Limit alcohol & caffeine – both can disrupt gut motility and increase yeast growth.
• Track symptoms – a simple diary (food, timing, symptoms) helps identify triggers.
• Exercise – moderate activity (30 min walking) stimulates intestinal transit.
• Mind‑body care – stress reduction (yoga, meditation) lowers cortisol, which can affect gut flora.

Follow‑up Schedule

After completing antimicrobial therapy, repeat breath testing 2–4 weeks later to confirm eradication. If symptoms recur, a second course or a rotating antimicrobial protocol may be needed. Regular labs (CBC, vitamin B12, iron, liver function) every 6‑12 months are advisable.

Prevention

Preventive measures target the underlying mechanisms that allow yeast to flourish.

• Use PPIs judiciously – discuss tapering or alternatives with your doctor.
• Maintain optimal blood sugar – uncontrolled diabetes impairs motility.
• Avoid unnecessary antibiotics – they disrupt bacterial competitors of yeast.
• Incorporate fiber gradually – soluble fibers (e.g., psyllium) support regular bowel movements without over‑feeding yeast.
• Regular physical activity – promotes gut transit.
• Screen for structural problems – especially after abdominal surgery; early correction reduces risk.

Complications

If left untreated, yeast‑dominant SIBO can lead to:

• Malabsorption & nutrient deficiencies – leading to anemia, osteoporosis, and neuropathy.
• Weight loss or failure to thrive in severe cases.
• Progression to intestinal inflammation – chronic SIBO is linked with microscopic colitis.
• Systemic fungal infection – rare but possible in immunocompromised patients.
• Exacerbation of existing conditions – worsened IBS, GERD, or functional dyspepsia.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, NIH (National Center for Biotechnology Information), Cleveland Clinic, WHO, peer‑reviewed journals (e.g., Gut, American Journal of Gastroenterology). All links open in a new tab.

```